According to the subgroup analysis of the patients’ disease types, the experimental group showed good therapeutic effects in improving the total effective rate of patients with CRS, reducing the Lund-Kennedy score, Lund-Mackay score, SNOT-20 score, nasal congestion, runny nose, headache, olfactory impairment and other VAS scores, total TCM symptom score, TNF-α, IL-6 and other aspects. Here, IL6 is linked to congenital rubella syndrome.